Medpace Holdings Inc (MEDP) - Total Liabilities
Based on the latest financial reports, Medpace Holdings Inc (MEDP) has total liabilities worth $1.62 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Medpace Holdings Inc's assets to evaluate the company's liquid asset resilience ratio.
Medpace Holdings Inc - Total Liabilities Trend (2014–2025)
This chart illustrates how Medpace Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medpace Holdings Inc total assets.
Medpace Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Medpace Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Franklin Resources Inc
NYSE:BEN
|
USA | $19.49 Billion |
|
Mizrahi Tefahot
TA:MZTF
|
Israel | ILA489.83 Billion |
|
Banco Bradesco S.A.
SA:BBDC3
|
Brazil | R$2.25 Trillion |
|
SCB X Public Company Limited
BK:SCB
|
Thailand | ฿2.95 Trillion |
|
Shanghai Precise Packaging Co Ltd
SHE:300442
|
China | CN¥30.60 Billion |
|
Beiersdorf Aktiengesellschaft
F:BEIA
|
Germany | €4.14 Billion |
|
Clean Harbors Inc
NYSE:CLH
|
USA | $4.91 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr40.87 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Medpace Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Medpace Holdings Inc to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medpace Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medpace Holdings Inc (2014–2025)
The table below shows the annual total liabilities of Medpace Holdings Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.52 Billion | +18.90% |
| 2024-12-31 | $1.28 Billion | +16.16% |
| 2023-12-31 | $1.10 Billion | +13.64% |
| 2022-12-31 | $966.11 Million | +36.65% |
| 2021-12-31 | $707.01 Million | +20.88% |
| 2020-12-31 | $584.90 Million | +40.33% |
| 2019-12-31 | $416.79 Million | +10.19% |
| 2018-12-31 | $378.23 Million | -15.42% |
| 2017-12-31 | $447.19 Million | +21.39% |
| 2016-12-31 | $368.39 Million | -35.43% |
| 2015-12-31 | $570.57 Million | -17.90% |
| 2014-12-31 | $694.94 Million | -- |
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medica… Read more